Iovance stock drops 90% despite historic approval for Amtagvi. Click here for a full investment analysis of IOVA stock.

Dr. Simone Steiner will focus on improving the manufacturing processes of individualized immunotherapies based onmyvac ® platform  Strasbourg, France, April 1, 2025, 5:45 p.m. CET — Transgene ...

Discover why John B. Sanfilippo & Son might be an undervalued gem. Learn about its strong dividend yield, growth metrics, and ...

Cannabis Growth Cannabis has been a booming industry in the USA and many other countries in the past decade. This followed a slow, but steady trend toward full legalization, even if doing so at the US ...

Full-year results and business updateClinical proof of principle obtained in Phase I adjuvant head and neck cancer trial with individualized ...

IO Biotech, a Danish med-tech company, has obtained €57.5 million in venture debt financing from the European Investment Bank, with backing fro ...

A recent study released by researchers from Pohang University of Science and Technology (POSTECH) opens the door for more ...

As part of an effort to increase its cell therapy manufacturing, Iovance Biotherapeutics is planning to add hundreds of new jobs at its manufacturing site at the Philadelphia Navy Yard, writes John ...

We've identified the following companies as similar to Scandion Oncology A/S because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to ...

OSLO, Norway, March 20, 2025 /PRNewswire/ -- Agilyx ASA (OSE: AGLX) (OTCQX: AGXXF) ("Agilyx" or "the company") announces that production of styrene via Styrenyx, its proprietary polystyrene ...

Some hoped the biotech's stock could soar due to another ... On March 11, Viking Therapeutics announced it had signed a $150 million manufacturing agreement with CordenPharma for both versions ...

But, having made a second-generation molecule its lead candidate last year, the biotech isn’t currently planning to file for batoclimab approval in myasthenia gravis or chronic inflammatory ...